Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Robert M. Herndon"'
Autor:
Robert M Herndon, MD
Knowledge has been described as being like an expanding sphere with the volume of knowledge contacting a surface on the unknown. This new comprehensive review of the many fields of basic and clinical research that impact our understanding of multiple
Autor:
David Leppert, Olga Ciccarelli, Maria Pia Sormani, Claudia A. M. Wheeler-Kingshott, Davorka Tomic, Elisabetta Verdun di Cantogno, David Baker, Gavin Giovannoni, David L. Selwood, Robert Hyde, Paul M. Matthews, Klaus Schmierer, Shibeshih Belachew, Daniele Carassiti, Gary Cutter, Robert M. Herndon, Ali-Frederic Ben-Amor, Harold Koendgen, Volker Knappertz
Publikováno v:
Multiple Sclerosis and Related Disorders. 12:70-78
Trials of anti-inflammatory therapies in non-relapsing progressive multiple sclerosis (MS) have been stubbornly negative except recently for an anti-CD20 therapy in primary progressive MS and a S1P modulator siponimod in secondary progressive MS. We
Autor:
Robert M. Herndon
Publikováno v:
International journal of MS care. 21(4)
Autor:
Robert M Herndon
Publikováno v:
Journal of Neurology and Neuroscience.
Differentiation of Neuromyelitis Optica from Multiple Sclerosis on Spinal Magnetic Resonance Imaging
Autor:
Bruce Schlakman, Joseph L. Gatlin, Majid Khan, Robert M. Herndon, Alan D. Penman, Saurabh Lalan
Publikováno v:
International Journal of MS Care. 14:209-214
In order to examine the accuracy of magnetic resonance imaging (MRI)–based diagnosis of neuromyelitis optica (NMO) versus multiple sclerosis (MS), we performed a retrospective, rater-blinded review of 29 cases of NMO and 30 cases of MS using the cr
Autor:
Robert M. Herndon
This chapter discusses the challenges involved in measuring disease activity and progression in multiple sclerosis and how different aspects of the disease are measured in clinical trials. Metrics have been developed to assess multiple aspects of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42f411f0bca33784270134e0040914a4
https://doi.org/10.1093/med/9780199341016.003.0011
https://doi.org/10.1093/med/9780199341016.003.0011
Autor:
Robert M. Herndon
Publikováno v:
International Journal of MS Care. 11:99-106
Autor:
P. Kinkel, Mark A. Agius, K. Bashir, Daniel D. Mikol, Syed A. Rizvi, Omar Khan, Victor M. Rivera, Rifaat Bashir, Carmelo Tornatore, M. A. Picone, T. E. Collins, Robert M. Herndon, H. Zwibel, Bruce A. Cohen, Douglas Jeffery, Edward Fox
Publikováno v:
Neurology. 63:S33-S40
Multiple sclerosis (MS) is an immune-mediated neurologic disease in which acute inflammatory events early in the disease course contribute to subsequent neurologic disability. The early relapsing inflammatory phase is followed by a progressive degene
Autor:
Nicola Ward, Robert M. Herndon, Michelle Keating, Suzanne C. Smeltzer, Judy Wollin, Deborah M. Miller
Publikováno v:
International Journal of MS Care. 6:140-143
Publikováno v:
International Journal of MS Care. 4:170-173
The new international panel guidelines for diagnosis of multiple sclerosis (MS) raised a number of concerns regarding their use and application, particularly in relation to their impact on treatment issues and options. As a result, a consensus panel